Dry-reagent disposable dipstick test for visual screening of seven leukemia-related chromosomal translocations

Nucleic Acids Research

Volumn 35, Issue 4, 2007, Pages

  Kalogianni, Despina P ^a   Bravou, Vasiliki ^b   Christopoulos, Theodore K ^a,c   Ioannou, Penelope C ^d   Zoumbos, Nicholas C ^b  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c INSTITUTE OF CHEMICAL ENGINEERING SCIENCES   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BCR ABL PROTEIN; BUFFER; CYTARABINE; GOLD; HYDROXYUREA; IMATINIB; INTERFERON; NANOPARTICLE; NUCLEOPHOSMIN; PROMYELOCYTIC LEUKEMIA PROTEIN; REAGENT; STREPTAVIDIN; TRANSCRIPTION FACTOR RUNX1; ZINC FINGER PROTEIN; ABL BCR FUSION PROTEIN, HUMAN; ABL-BCR FUSION PROTEIN, HUMAN; AML1 ETO FUSION PROTEIN, HUMAN; AML1-ETO FUSION PROTEIN, HUMAN; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA-RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; ADULT; AGAR GEL ELECTROPHORESIS; AGED; AMINO ACID SEQUENCE; ANALYTIC METHOD; ARTICLE; BIOASSAY; BONE MARROW TRANSPLANTATION; CELL STRAIN K 562; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 5; CHROMOSOME TRANSLOCATION 8; CHROMOSOME TRANSLOCATION 9; CHRONIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISPOSABLE EQUIPMENT; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYBRIDIZATION; INTERMETHOD COMPARISON; LEUKEMIA; LEUKOCYTE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; ACUTE DISEASE; CHRONIC MYELOID LEUKEMIA; EVALUATION; GENE TRANSLOCATION; GENETICS; METHODOLOGY; MYELOID LEUKEMIA; NUCLEIC ACID HYBRIDIZATION; PROMYELOCYTIC LEUKEMIA;

ACUTE DISEASE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; FUSION PROTEINS, BCR-ABL; HUMANS; INDICATORS AND REAGENTS; LEUKEMIA; LEUKEMIA, MYELOID; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; LEUKEMIA, PROMYELOCYTIC, ACUTE; NUCLEIC ACID HYBRIDIZATION; ONCOGENE PROTEINS, FUSION; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; TRANSLOCATION, GENETIC;

EID: 34047158698     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkl1097     Document Type: Article

References (34)

1. Bench,A.J., Erber,W.N. and Scott,M.A. (2005) Molecular genetic analysis of haematological malignancies: I. Acute leukemias and myeloproliferative disorders. Clin. Lab. Haem., 27, 148-171.
2. Crisan,D. (2000) Molecular mechanisms in myelodysplastic syndromes and implications for evolution to acute leukemias. Clin. Lab. Med., 20, 49-69.
3. Pandolfi,P.P. (2001) Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia. Hum. Mol. Genet., 10, 769-775.
4. Liu Yin,J.A. (2002) Minimal residual disease in acute myeloid leukemia. Best Pract. Res. Clin. Haematol., 15, 119-135.
5. Liu Yin,J.A. (1999) Detection of minimal residual disease in acute myeloid leukemia: Methodologies, clinical and biological significance. Br. J. Haematol., 106, 578-590.
6. Burmeister,T. and Thiel,E. (2001) Molecular genetics in acute and chronic leukemias. J. Cancer Res. Clin. Oncol., 127, 80-90.
7. Falini,B. and Mason,D.Y. (2002) Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: Clinical value of their detection by immunocytochemistry. Blood, 99, 409-426.
8. Bortolin,S. and Christopoulos,T.K. (1994) Time-resolved immunofluorometric determination of specific mRNA sequences amplified by the polymerase chain reaction. Anal. Chem., 66, 4302-4307.
9. Bortolin,S. and Christopoulos,T.K. (1995) Detection of BCR-ABL transcripts from the philadelphia translocation by hybridization in microtiter wells and time-resolved immunofluorometry. Clin. Chem., 41, 693-699.
10. Zhang,Q.Y., Garner,K. and Viswanatha,D.S. (2002) Rapid detection of leukemia-associated translocation fusion genes using a novel combined RT-PCR and flow-cytometric method. Leukemia, 16, 144-149.
11. Chen,I.M., Chakerian,A., Combs,D., Garner,K. and Viswanatha,D.S. (2004) Post-PCR multiplex fluorescent ligation detection assay and flow cytometry for rapid detection of gene-specific translocations in leukemia. Am. J. Clin. Pathol., 122, 783-793.
12. Nashed,A.L., Rao,K.W. and Gulley,M.L. (2003) Clinical applications of BCR-ABL molecular testing in acute leukemia. J. Mol. Diagn., 5, 63-72.
13. Zhang,T., Xiong,H., Kan,L.-X., Zhang,C.-K., Jiao,X.-F., Fu,G., Zhang,Q.-H., Lu,L., Tong,J.-H., Gu,B.-W. et al. (1999) Genomic sequence, structural organization, molecular evolution, and aberrant rearrangement of promyelocytic leukemia zinc finger gene. Proc. Natl. Acad. Sci. U.S.A., 96, 11422-11427.
14. Yin,J.A. and Frost,L. (2003) Monitoring AML1-ETO and CBFbeta-MYH11 transcripts in acute myeloid leukemia. Curr. Oncol. Rep., 5, 399-404.
15. Shigesada,K., van de Sluis,B. and Liu,P.P. (2004) Mechanism of leukemogenesis by the inv(16) chimeric gene CBFB/PEBP2BMYH11. Oncogene, 23, 4297-4307.
16. Glynou,K., Ioannou,P.C., Christopoulos,T.K. and Syriopoulou,V. (2003) Oligonucleotide-functionalized gold nanoparticles as probes in a dry-reagent strip biosensor for DNA analysis by hybridization. Anal. Chem., 75, 4155-4160.
17. Li,J.Y., English,M.A., Ball,H.J., Yeyati,P.L., Waxman,S. and Licht,J.D. (1997) Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein. J. Biol. Chem., 272, 22447-22455.
18. Licht,J.D., Shaknovich,R., English,M.A., Melnick,A., Li,J.Y., Reddy,J.C., Dong,S., Chen,S.J., Zelent,A. and Waxman,S. (1996) Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia. Oncogene 12, 323-336.
19. Grimwade,D., Biondi,A., Mozziconacci,M.J., Hagemeijer,A., Berger,R., Neat,M., Howe,K., Dastugue,N., Jansen,J., Radford-Weiss,I. et al. (2000) Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): Results of the European Working Party. Blood, 96, 1297-1307.
20. Jansen,J.H., de Ridder,M.C., Geertsma,W.M.C., Erpelinck,C.A., van Lom,K., Smit,E.M.E., Slater,R., vd Reijden,B.A., de Greef,G.E., Sonneveld,P. et al. (1999) Complete remission of t(11;17) Positive acute promyelocytic leukemia induced by all-trans retinoic acid and granulocyte colony-stimulating factor. Blood, 94, 39-45.
21. Wells,R.A., Catzavelos,C. and Kamel-Reid,S. (1997) Fusion of retinoic acid receptor α to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukemia. Nature Genet., 17, 109-113.
22. Van Dongen,J.J.M., Macintyre,E.A., Gabert,J.A., Delabesse,E., Rossi,V., Saglio,G., Gottardi,E., Rambaldi,A., Dotti,G., Griesinger,F. et al. (1999) Standarized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Leukemia, 13, 1901-1928.
23. Galvan,B. and Christopoulos,T.K. (1997) Quantitative reverse transcriptase-polymerase chain reaction for prostate-specific antigen mRNA. Clin. Biochem., 30, 391-397.
24. Weller,M.G. (2000) Immunochromatographic techniques-a critical review. Fresenius J. Anal. Chem., 366, 635-645.
25. Hayat,M.A. (1989) Colloidal gold: Principles, methods and applications. Academic press, CA. Academic press, CA.
26. + acute myeloid leukemia based on quantification of fusion transcripts. Blood, 102, 2746-2755.
27. Bortolin,S. and Christopoulos,T.K. (1996) Quantitative RT-PCR combined with time-resolved fluorometry for determination of BCR-ABL mRNA. Clin.Chem., 42, 1924-1929.
28. Schüler,F. and Dölken,G. (2006) Detection and monitoring of minimal residual disease by quantitative real-time PCR. Clin. Chim. Acta, 363, 147-156.
29. Press,R.D., Love,Z., Tronnes,A.A., Yang,R., Tran,T., Mongoue-Tchokote,S., Mori,M., Mauro,M.J., Deininger,M.W. and Druker,B.J. (2006) BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate-treated patients with CML. Blood, 107, 4250-4256.
30. Neumann,F., Herold,C., Hildebrandt,B., Kobbe,G., Aivado,M., Rong,A., Free,M., Rössig,R., Fenk,R., Schneider,P. et al. (2003) Quantitative real-time reverse-transcription polymerase chain reaction for diagnosis of BCR-ABL positive leukemias and molecular monitoring following allogeneic stem cell transplantation. Eur. J. Haematol., 70, 1-10.
31. Elmaagacli,A.H., Beelen,D.W., Opalka,B., Seeber,S. and Schaefer,U.W. (2000) The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage. Ann. Hematol., 79, 424-431.
32. Deininger,M.W. (2005) Management of early stage disease. Hematology, 1, 174-182.
33. Thomas,D.A., Faderl,S., Cortes,J., O'Brien,S., Giles,F.J., Kornblau,S.M., Garcia-Manero,G., Keating,M.J., Andreeff,M. and Jeha,S. (2004) Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate. Blood, 103, 4396-4407.
34. Guo,J.Q., Lin,H., Kantarjian,H., Talpaz,M., Champlin,R., Andreeff,M., Glassman,A. and Arlinhaus,R.B. (2002) Comparison of competitive-nested PCR and real-time PCR in detecting BCRABL fusion transcripts in chronic myeloid leukemia patients. Leukemia, 16, 2447-2453.